Form 4 for ESAB ESAB Corp
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001673243-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-25 | 2026-02-23 | ESAB | Kambeyanda Shyam | Pres, CEO, Dir | S - Sale+OE | $123.79 | -59.4K | 102.2K | -37% | -$7.35M |
| D | 2026-02-25 | 2026-02-23 | ESAB | Kambeyanda Shyam | Pres, CEO, Dir | F - Tax | $122.65 | -2,091 | 102.2K | -2% | -$256.5K |
| DM | 2026-02-25 | 2026-02-23 | ESAB | Kambeyanda Shyam | Pres, CEO, Dir | M - OptEx | $33.49 | +63.9K | 159.3K | +67% | +$2.14M |
| DM | 2026-02-25 | 2026-02-23 | ESAB | Kambeyanda Shyam | Pres, CEO, Dir | M - OptEx | $0.00 | -63.9K | 4,467 | -93% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2026-02-23 | S | D | 12,705 | $123.72 | 114,277 | D | — | — | (F3) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.460 to $124.430, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| 2 | Common | Common stock, par value $0.001 | 2026-02-23 | F | D | 2,091 | $122.65 | 102,239 | D | — | — | (F9) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| 3 | Common | Common stock, par value $0.001 | 2026-02-23 | M | A | 4,466 | — | 104,330 | D | — | — | (F8) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. |
| 4 | Common | Common stock, par value $0.001 | 2026-02-23 | S | D | 1,700 | $128.75 | 99,864 | D | — | — | (F7) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.560 to $128.950, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4. |
| 5 | Common | Common stock, par value $0.001 | 2026-02-23 | S | D | 600 | $127.86 | 101,564 | D | — | — | (F6) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.375 to $128.200, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. |
| 6 | Common | Common stock, par value $0.001 | 2026-02-23 | M | A | 59,404 | $33.49 | 159,268 | D | — | — | |
| 7 | Common | Common stock, par value $0.001 | 2026-02-23 | S | D | 32,286 | $123.00 | 126,982 | D | — | — | (F2) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.460 to $123.455, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| 8 | Common | Common stock, par value $0.001 | 2026-02-23 | S | D | 10,813 | $125.00 | 103,464 | D | — | — | (F4) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.465 to $125.390, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. |
| 9 | Common | Common stock, par value $0.001 | 2026-02-23 | S | D | 1,300 | $125.79 | 102,164 | D | — | — | (F5) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.495 to $125.940, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2026-02-23 | M | D | 59,404 | $0.00 | 0 | D | $33.49 · 2022-04-05 to 2026-02-24 | 59,404 Common stock, par value $0.001 | |
| 11 | Derivative | Restricted Stock Units | 2026-02-23 | M | D | 4,466 | $0.00 | 4,467 | D | — · 2025-02-22 to 2027-02-22 | 4,466 Common stock, par value $0.001 | (F8) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. (F10) This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. The remaining restricted stock units will vest on February 22, 2027. |